C2Dx, Inc.
About C2Dx, Inc.
Company overview
C2dx, Inc. is a technology company that specializes in the development and implementation of advanced diagnostic solutions for the healthcare industry. Founded by a team of experts in medical imaging and artificial intelligence, the company is committed to revolutionizing medical diagnostics through innovative software and hardware solutions. C2dx's mission is to empower healthcare professionals with accurate and timely diagnostic information, enabling them to make well-informed decisions that lead to improved patient outcomes. The company places a strong emphasis on research and development, leveraging the latest breakthroughs in AI and imaging technologies to create transformative medical devices and software. Product Breakdown: Diagnostic Imaging Software: C2dx's flagship product is its state-of-the-art diagnostic imaging software. This software leverages artificial intelligence and machine learning algorithms to enhance medical image analysis. It provides radiologists and other medical professionals with advanced tools for image segmentation, feature extraction, and anomaly detection. The software is designed to streamline the diagnostic process, leading to faster and more accurate diagnoses. Computer-Aided Detection (CAD) Systems: C2dx offers computer-aided detection systems that integrate seamlessly with existing medical imaging equipment. These CAD systems assist radiologists in identifying potential abnormalities and markers of diseases in medical images. By acting as a second set of eyes, the CAD systems enhance diagnostic accuracy and serve as valuable decision support tools for healthcare professionals. Mobile Medical Imaging Apps: C2dx has developed mobile applications that allow healthcare providers to access medical images securely and remotely. These apps facilitate collaboration between healthcare professionals and enable timely consultations, even when they are not physically present in the same location. The mobile apps comply with stringent security and privacy standards to safeguard patient data. 3D Visualization and Virtual Reality (VR) Solutions: C2dx offers advanced 3D visualization tools and virtual reality solutions that enable a more immersive and detailed view of medical images. These technologies enhance the interpretation of complex cases and support pre-operative planning for surgical procedures. The VR solutions provide an intuitive and interactive way for medical professionals to interact with patient data, leading to better treatment decisions. Cloud-Based Medical Image Storage and Management: C2dx provides secure cloud-based storage and management solutions for medical images and patient data. The platform is designed to facilitate easy access, sharing, and archiving of medical images, ensuring seamless collaboration between healthcare facilities and professionals. The cloud-based system adheres to strict data security regulations and ensures patient privacy.
Keywords
Revenue
EBITDA
Valuation
| Line Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenues | $380 MM | $250 MM | $90 MM | $120 MM | $65 MM |
| Gross Profit | $190 MM | $125 MM | $45 MM | $60 MM | $32.50 MM |
| Net Income (Loss) | $43 MM | $25 MM | $9 MM | $12 MM | $6.50 MM |
| Line Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | $850 MM | $720 MM | $680 MM | $650 MM | $600 MM |
| Total Liabilities | $450 MM | $400 MM | $380 MM | $350 MM | $320 MM |
| Total Equity | $400 MM | $320 MM | $300 MM | $300 MM | $280 MM |
Ratios
Employee Figures
Key Executives
| Name | Title | Socials | Phone | |
|---|---|---|---|---|
| John Doe | Employee | ---------- | ---------- | ---------- |
| Jane Doe | Employee | ---------- | ---------- | ---------- |
| John Doe | Employee | ---------- | ---------- | ---------- |
| John Doe | Employee | ---------- | ---------- | ---------- |
401K
M&A2024-03-15Completed
Investor Sponsors NorthBridge PE | Stake Tags 100% |
Deal Amount $120M | Is PE deal Yes |
Target Company Valuation $1.20 MM | Is deal PE backed Yes |
Techniques Acquisition of Assets, Taken Private | Total Acquired 100% |
Investor Sponsors
Deal Amount
$120M
Target Company Valuation
$1.20 MM
Techniques
Acquisition of Assets, Taken Private
Stake Tags
100%
Is PE deal
Yes
Is deal PE backed
Yes
Total Acquired
100%
Secondary Transaction2023-09-01Canceled
Investor Sponsors -- | Stake Tags Majority |
Deal Amount Undisclosed | Is PE deal No |
Target Company Valuation -- | Is deal PE backed Yes |
Techniques Secondary Sale, Management Buy-out (MBO) | Total Acquired 65% |
Investor Sponsors
--
Deal Amount
Undisclosed
Target Company Valuation
NaN
Techniques
Secondary Sale, Management Buy-out (MBO)
Stake Tags
Majority
Is PE deal
No
Is deal PE backed
Yes
Total Acquired
65%
© 2026 PrivCo Holding Inc. All rights reserved.
No AI Training or Automated Data Extraction.
Use of this page or any content or data made available by PrivCo for scraping, crawling, indexing, caching, extracting, copying, reproducing, storing, or for training or developing any artificial intelligence or machine learning system is strictly prohibited without prior written consent. All access to and use of this page and PrivCo's services are subject to the PrivCo Terms of Use: https://www.privco.com/terms-of-use. No license or right is granted by implication or otherwise.